Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors
Year: 1999
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm990345w
Institutions: AstraZeneca (United Kingdom), AstraZeneca (France)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1964203908
